Novo Nordisk (NVO) shares inched higher on Monday after the Danish pharmaceutical behemoth announced a major strategic refresh. The company said it’s rebranding as Novo, while introducing a new visual identity and corporate culture initiative dubbed “The Novo Way.”
The disclosure arrives at a time when Novo Nordisk stock has fallen out of favor with investors, currently down more than 30% versus its year-to-date high.
